Prenetics Global Limited - Class A Ordinary Share (PRE)

CHARLOTTE, N.C., June 12, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the first quarter ended March 31, 2025, along with recent business updates.

David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All

Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University

CHARLOTTE, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today the Company will participate in the 37th Annual ROTH Conference being held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort in Dana Point, CA.

Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024

CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare company, today announced a groundbreaking genomics-based partnership with Humanity Protocol, a decentralized identity verification company. This collaboration leverages Prenetics’ advanced genetic testing capabilities to underpin decentralized identity verification.

The Next Big Thing in Wellness? IM8 Lands in the U.S. with a Star-Studded Launch. David Beckham and a world-class scientific team are putting the focus back on foundational health

– David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall Wellness

RALEIGH, NC / ACCESSWIRE / December 6, 2024 / iAccess Alpha's "Buyside Best Ideas Virtual Winter Conference" is taking place on December 10-11, 2024.

CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics’ IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the International Space Station (ISS). Launched via SpaceX CRS-31 on November 4th at 9:29 pm EST, the mission aims to study accelerated aging and longevity by leveraging microgravity's unique environment to accelerate aging processes at the cellular level.

CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially

Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8

Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8

CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap Conference being held on November 13-14, 2024.

HONG KONG, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta at US$200 million and underscores Tencent’s endeavor to advancing AI-powered innovations in healthcare.

Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024Enters U.S. Health Market in October with IM8, a New Health and Wellness BrandRe-affirms Revenue Target to Exceed US$33 million for FY 2024

Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States

As the global population ages and the prevalence of chronic diseases rises, there is an increasing demand for innovative solutions that can enhance prevention, diagnosis, and treatment. The health sciences industry is undergoing a significant transformation, driven by advancements in genomics, personalized medicine, and early detection technologies. One major example is the global cancer diagnostics market, which was valued at USD 19.5 billion in 2023 and is expected to reach USD 54.6 billion by 2032, growing at a CAGR of 12.1% during the forecast period. In this dynamic landscape, one company has been making waves as of recent, Prenetics Global Limited (NASDAQ: PRE) .

Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness

Cancer remains one of the most formidable challenges in modern medicine, claiming millions of lives each year. Early detection and personalized treatment have become critical in improving survival rates. In this context, the genomics and health sciences sectors are emerging as pivotal technologies. Among these, Prenetics Global Limited (NASDAQ: PRE) could be a stand out for investors.

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter

~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders ~